FDA approves two new HIV oral drugs

HIV oral drugs

The U.S. Food and Drug Administration has approved two HIV oral drugs produced by Merck & Co Inc, nearly two months ahead of schedule the company said on Thursday.

The drugs have been approved to treat adults with the most common strain of the virus, HIV-1, and target patients who have received no prior antiretroviral treatment, Merck said.

READ: 95% HIV and AIDS funding in Nigeria comes from abroad says NACA

Delstrigo, a once-a-day combination tablet, has been approved with a boxed warning, the agency’s strictest, to flag risk of worsening hepatitis B infection.

Pifeltro, the second drug, is an oral medicine to be administered in combination with other antiretrovirals, Merck said.

READ ALSO: 2,131 pregnant women test positive to HIV in Lagos

The company also said it expects to stock both the treatments through wholesalers within a month.

Facebook Comments
Disclaimer: Pinnaclehealthradio.org does not guarantee any specific results as a result of the procedures mentioned here and the results may vary from person to person. The topics in these pages including text, graphics, videos and other material contained on this website are for informational purposes only and not to be substituted for professional medical advice.

Leave a Reply